Mechanistically, CDK4/6 inhibitors induce tumor cell cycle arrest and apoptosis, while chemotherapy-induced DNA damage may sensitize tumors to cell cycle-targeted therapies (Bisi et al., 2016; He et al., 2017). The gene discussed is CDK4; the disease is neoplasm.